Invention Grant
- Patent Title: Viral replication inhibitors
-
Application No.: US14346777Application Date: 2012-09-26
-
Publication No.: US10550123B2Publication Date: 2020-02-04
- Inventor: Dorothée Bardiot , Gunter Carlens , Kai Dallmeier , Suzanne Kaptein , Michael McNaughton , Arnaud Marchand , Johan Neyts , Wim Smets , Mohamed Koukni
- Applicant: KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. Leuven R&D
- Applicant Address: BE Leuven
- Assignee: Katholieke Universiteit Leuven, K.U. Leuven R&D
- Current Assignee: Katholieke Universiteit Leuven, K.U. Leuven R&D
- Current Assignee Address: BE Leuven
- Agency: Amster, Rothstein & Ebenstein LLP
- Priority: GB1116559.4 20110926
- International Application: PCT/EP2012/069007 WO 20120926
- International Announcement: WO2013/045516 WO 20130404
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D403/12 ; C07D401/14 ; C07D403/08 ; C07D405/12 ; C07D409/08 ; C07D413/08 ; C07D209/14 ; C07D513/04 ; C07D401/06 ; C07D401/08 ; C07D401/12 ; C07D403/06 ; C07D403/10 ; C07D405/06 ; C07D409/06 ; C07D409/12 ; C07D413/06 ; C07D413/12 ; C07D417/14 ; C07D471/04 ; C07D495/04 ; C07D498/04

Abstract:
The present invention relates to a series of novel compounds, methods to prevent or treat viral infections in animals by using the novel compounds and to said novel compounds for use as a medicine, more preferably for use as a medicine to treat or prevent viral infections, particularly infections with RNA viruses, more particularly infections with viruses belonging to the family of the Flaviviridae, and yet more particularly infections with the Dengue virus. The present invention furthermore relates to pharmaceutical compositions or combination preparations of the novel compounds, to the compositions or preparations for use as a medicine, more preferably for the prevention or treatment of viral infections. The invention also relates to processes for preparation of the compounds.
Public/Granted literature
- US20140213586A1 VIRAL REPLICATION INHIBITORS Public/Granted day:2014-07-31
Information query